This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Hadasit Medical Research Services and Development Ltd.. Active years: 2017-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 911 
1 out of 181 Years Active: 2017-2022
Title: Jacob Rachmilewitz: Innovator in Injectable Implants and Tissue Regeneration
Introduction
Jacob Rachmilewitz is a notable inventor based in Modiin, Israel. He has made significant contributions to the fields of medical technology and tissue engineering. With a total of 2 patents, Rachmilewitz has focused on developing innovative solutions for bone healing and tissue regeneration.
Latest Patents
Rachmilewitz's latest patents include groundbreaking inventions. The first is an injectable implant composition designed to accelerate bone fracture healing, treat dental or oral pathologies, and facilitate controlled drug delivery. The second patent pertains to a tissue regeneration membrane. This membrane comprises at least one positively charged, synthetic, hydrophobic polymer, one hydrophilic polymer, and one plasticizer. It is flexible and supports cell adherence, proliferation, and differentiation. The invention also outlines methods for promoting tissue regeneration in defected tissue regions using these membranes.
Career Highlights
Throughout his career, Rachmilewitz has worked with esteemed organizations. He has been associated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Hadasit Medical Research Services and Development Ltd. His work has significantly impacted the development of medical technologies.
Collaborations
Rachmilewitz has collaborated with notable professionals in his field, including Michael M Friedman and Rami Mosheiff. These collaborations have further enhanced his research and development efforts.
Conclusion
Jacob Rachmilewitz is a distinguished inventor whose work in injectable implants and tissue regeneration has the potential to transform medical practices. His innovative patents and collaborations reflect his commitment to advancing healthcare technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile